FDA Import Refusal SCS-0631682-4/11/1 — UCB Pharma S.A.
The FDA refused shipment SCS-0631682-4/11/1 from UCB Pharma S.A. (Belgium) on Jun 4, 2020. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jun 4, 2020
- Country
- Belgium
- Product Category
- Drugs and Biologics
- Product Code
- 66VCS99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75